## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tb-500-nerve-damage`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tb-500-nerve-damage/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-nerve-damage/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tb-500-nerve-damage/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-nerve-damage/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tb-500-nerve-damage/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tb-500-nerve-damage` v2 · content_hash `6f636fb0631276dd…` · thread_head genesis · 18 DIVs
- **thesis (c1):** No completed human interventional trials exist for TB-500 or thymosin beta-4 in nerve damage or neuropathy.
  - c2 [preclinical/active] In a 2012 mouse diabetic neuropathy model, thymosin beta-4 improved sciatic nerve conduction velocity versus controls.
  - c3 [preclinical/active] In a 2014 rat spinal cord injury model, thymosin beta-4 increased surviving neurons/oligodendrocytes and improved locomotor scores.
  - c4 [anecdotal/active] Reddit users report variable anecdotal improvements in nerve-related pain when stacking TB-500 with BPC-157.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tb-500-nerve-damage/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tb-500-nerve-damage/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tb-500-nerve-damage`
- **title:** TB-500 for Nerve Damage: Evidence-Graded Review
- **url:** https://miscsubjects.com/a/tb-500-nerve-damage
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:16.594Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Nerve damage involves layers of degeneration where repair pathways stall. Axons may fail to regrow due to disrupted actin cytoskeleton and poor cell migration to the injury site. Inflammation can persist instead of clearing, blocking new blood vessel formation and tissue rebuilding. In models of diabetic neuropathy or spinal cord injury, conduction velocity drops and functional recovery lags because repair cells do not reach the damage effectively. TB-500 targets these repair layers rather than suppressing symptoms.

## Why TB-500 might help you

1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

## How these fit together

Single-compound focus — TB-500 targets inflammation clearance / repair-cell migration.

## What the evidence actually shows

No completed human interventional trials test TB-500 or thymosin beta-4 specifically for nerve damage or neuropathy (preclinical tier from scoping reviews). A 2026 scoping review of 80 studies found the evidence base weighted toward in vitro and mixed designs, with human data limited to ocular and wound contexts and no direct TB-500 nerve studies. Animal studies provide the primary data. In a 2012 mouse model of diabetic peripheral neuropathy, thymosin beta-4 treatment improved sciatic nerve conduction velocity and neurovascular function compared to controls (preclinical tier). In a 2014 rat spinal cord injury model, thymosin beta-4 given 30 minutes to 5 days post-injury increased surviving neurons and oligodendrocytes, raised myelin basic protein levels by 57.8%, reduced activated microglia by 36.9%, lowered pro-inflammatory cytokines, and improved locomotor scores on Basso-Beattie-Bresnahan scale versus saline (preclinical tier). A 2012 rat traumatic brain injury study showed early (6-hour) thymosin beta-4 reduced cortical lesion volume by up to 30% and improved spatial learning and sensorimotor scores; delayed (24-hour) treatment preserved hippocampal neurons and aided functional recovery without shrinking lesion size (preclinical tier). A 2015 press release on long-term thymosin beta-4 in diabetic mice reported restored sciatic nerve function and prevented neuropathy progression (preclinical tier). A 2026 mouse Alzheimer's model found TB-500 and Ac-SDKP reduced neurite atrophy, inhibited microglial M1 polarization, and alleviated cognitive deficits (preclinical tier). All nerve-related claims remain preclinical; human data are absent for this indication.

## What scientists say

Researchers note thymosin beta-4 participates in axonal path-finding, neurite formation, and neuronal survival, positioning it as a candidate neurorestorative agent in animal models (mechanistic tier). Reviews highlight its safety profile in completed human trials for other indications but call for more clinical research before application to neurological injury (mechanistic tier). No scientists claim proven efficacy in humans for nerve damage.

## What people say on Reddit

Anecdotal reports mention stacking TB-500 with BPC-157 for sciatica or peripheral nerve issues, with some users describing reduced foot pain or improved recovery after months of symptoms (anecdotal tier). Other threads express skepticism about cost and lack of regulation, with users advising against peptides pushed by physical therapists (anecdotal tier). Individual logs vary widely; some report noticeable changes in 2 weeks while others see minimal effect after months (anecdotal tier). These are self-reports, not controlled data.

## What people say on X

Limited public discussion; occasional mentions of TB-500 in broader peptide recovery contexts but no detailed nerve-damage case reports surfaced in searches (anecdotal tier). Posts remain sparse and unverified.

## What we do not know

Human efficacy, optimal timing, long-term outcomes, and direct comparison to standard care for any nerve condition remain unknown. Direct TB-500 data are minimal even in animals; most studies use full thymosin beta-4. No data address whether effects translate across different nerve injury types (traumatic, compressive, metabolic).

## Safety and limits

Thymosin beta-4 showed good tolerability in early human safety trials for non-nerve indications (human tier). Animal toxicology studies report no dose-dependent toxicity. However, TB-500 itself lacks dedicated human safety data for nerve use. All nerve-repair observations come from animal models; human evidence does not exist for this purpose. Research use only; not approved for any medical condition.

## Claims (4)

- **c1** [preclinical w=0.5] No completed human interventional trials exist for TB-500 or thymosin beta-4 in nerve damage or neuropathy.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [preclinical w=0.5] In a 2012 mouse diabetic neuropathy model, thymosin beta-4 improved sciatic nerve conduction velocity versus controls.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c3** [preclinical w=0.5] In a 2014 rat spinal cord injury model, thymosin beta-4 increased surviving neurons/oligodendrocytes and improved locomotor scores.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c4** [anecdotal w=0.3] Reddit users report variable anecdotal improvements in nerve-related pain when stacking TB-500 with BPC-157.
  - who_claims: grok/grok-4.3
  - sources: s4

## Voxel graph (4 atoms · 8 edges)
- full graph: https://miscsubjects.com/api/articles/tb-500-nerve-damage/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `989670c24f8cbbbe`

### s1 · review · http_403
- title: Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
- url: https://www.mdpi.com/2076-3417/16/12/6202
- summary: 2026 scoping review mapping 80 studies; no direct human TB-500 nerve trials identified.
- quote: Human evidence directly relevant to musculoskeletal applications was limited, and direct TB-500 evidence was minimal.
- claim_ids: c1
- hash: `06e5ffab01abd1e7`

### s2 · pubmed · ok
- title: Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Diabetic Mice
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/
- summary: 2012 mouse study showing improved nerve conduction with Tβ4.
- quote: The present study indicates that Tβ4 ameliorates diabetic peripheral neuropathy, evidenced by reduction of sciatic nerve conduction velocity deficits.
- claim_ids: c2
- hash: `44cc9306c9e6a983`

### s3 · pubmed · ok
- title: Beneficial effects of thymosin β4 on spinal cord injury in the rat
- url: https://pubmed.ncbi.nlm.nih.gov/24937047/
- summary: 2014 rat SCI study with histological and functional improvements.
- quote: Locomotor recovery was tested with the Basso-Beattie-Bresnahan scale... All behavioral assessments were markedly improved with Tβ4 treatment.
- claim_ids: c3
- hash: `d88e5efde07a9051`

### s4 · reddit · ok
- title: BPC-157 for long term nerve damage?
- url: https://www.reddit.com/r/BodyHackGuide/comments/1n264di/bpc157_for_long_term_nerve_damage/
- summary: User discussion on peptide stacks for nerve issues.
- quote: BPC-157 can help nerve repair and ease pain, especially stacked with TB-500.
- claim_ids: c4
- hash: `989670c24f8cbbbe`

## Provenance (2 model passes)
- chain valid: yes · head: `fcda2d0f877d91e9`

- write · grok/grok-4.3 · 2026-06-29T23:34 · hash `af6707540c8c`
- voxel_divide · owner · 2026-07-17T02:42 · hash `fcda2d0f877d`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tb-500-nerve-damage/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tb-500-nerve-damage/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tb-500-nerve-damage","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tb-500-nerve-damage|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tb-500-nerve-damage|tier|assertion`
- **iMessage ask:** `tb-500-nerve-damage|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tb-500-nerve-damage`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-nerve-damage/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*